CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Avid Bioservices Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Avid Bioservices Inc
14191 MYFORD ROAD
Phone: (714) 508-6100p:714 508-6100 TUSTIN, CA  92780  United States Ticker: CDMOCDMO
Business Summary
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
7/31/20244/30/2024YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board JosephCarleone 78 11/1/2017 11/1/2017
President, Chief Executive Officer, Director Nicholas S.Green 60 7/30/2020 7/30/2020
Chief Financial Officer Daniel R.Hart 50 8/1/2018 8/1/2018
7 additional Officers and Directors records available in full report.

Business Names
Business Name
CDMO
Peregrine (Beijing) Pharmaceutical Technology Ltd.
Peregrine Pharmaceuticals, Inc.
PPHM
Vascular Targeting Technologies, Inc.

General Information
Number of Employees: 371 (As of 4/30/2024)
Outstanding Shares: 63,955,784 (As of 11/6/2024)
Shareholders: 609
Stock Exchange: NASD
Federal Tax Id: 953698422
Fax Number: (714) 838-5817
Email Address: info@peregrineinc.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024